Remuneration Policy
Policy for remuneration of the board and management. The policy was approved by the general meeting on June 12, 2020.
- About us
ABOUT US
Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases.
READ MORE - What we do
WHAT WE DO
Bavarian Nordic focuses on developing product candidates to address cancer and infectious diseases.
READ MORE - INVESTORS
INVESTORS
Bavarian Nordic is committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Read more - Careers
CAREERS
Bavarian Nordic offers a challenging international working environment in which
READ MORE
job satisfaction and personal growth have a high priority.